Tus-Pharmaceutical Group Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 297.28 million compared to CNY 272.33 million a year ago. Revenue was CNY 300.77 million compared to CNY 275.09 million a year ago.

Net income was CNY 35.44 million compared to CNY 22.72 million a year ago. Basic earnings per share from continuing operations was CNY 0.148 compared to CNY 0.0949 a year ago. Diluted earnings per share from continuing operations was CNY 0.148 compared to CNY 0.0949 a year ago.